ANDA 88414, held by Sandoz. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 88414 (Phentermine Hydrochloride), held by Sandoz, was first approved by FDA on Oct 19, 1983, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 19, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride37.5MG · capsule;oral | Phentermine Hydrochloride | Discontinued |
| May 31, 2017 | Supplement 2Labeling · Standard review | Approved | None posted |
| Aug 20, 1991 | Supplement 1Labeling | Approved | None posted |
| Oct 19, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters